Evidence map›Paper›PMID 41450967›Full record

ArticleFrontiers in molecular biosciences2025

FluoTag-EMSA: a fast and accessible quantitative method to assess RNA-binding specificity using 3'-tagged hybrid duplexes.

Benjamin Rothé, Daniel B Constam

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Benjamin RothéEcole Polytechnique Fédérale de Lausanne (EPFL) SV ISREC, Lausanne, Switzerland.
Daniel B ConstamEcole Polytechnique Fédérale de Lausanne (EPFL) SV ISREC, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electrophoretic mobility shift assay (EMSA) is widely used to study RNA-protein interactions but remains limited by safety, cost, and time constraints associated with radioactive or covalent fluorescent labeling. Here, a novel method termed FluoTag-EMSA overcomes these hurdles by providing the RNA 3'ends with short sequence tags that can be hybridized to specific complementary fluorescent DNA probes, eliminating the need for chemical or enzymatic labeling steps. Specifically, two independent sequence tags are described that do not disrupt RNA folding and allow efficient annealing to complementary oligonucleotides carrying far-red/near-infrared dyes (700 nm and 800 nm), enabling direct in-gel fluorescence detection. Both tag/probe duplexes exhibit identical thermodynamic properties and can be used interchangeably. FluoTag-EMSA is a streamlined and reproducible non-radioactive alternative method for studying RNA-protein interactions without the need for specialized equipment.

Indexed as

electrophoretic mobility shift assay (EMSA)fluorescent RNA labelingFluoTag-EMSAnon-radioactive detectionribonucleoprotein complexes (RNPs)RNA-binding proteinRNA-protein interactionsRNA tagging

Identifiers

PMID41450967
PMCPMC12727980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.